NovaBay Pharmaceuticals, Inc. Quarterly Depreciation in USD from Q1 2015 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
NovaBay Pharmaceuticals, Inc. quarterly/annual Depreciation history and growth rate from Q1 2015 to Q3 2024.
  • NovaBay Pharmaceuticals, Inc. Depreciation for the quarter ending September 30, 2024 was $9K, a 30.8% decline year-over-year.
  • NovaBay Pharmaceuticals, Inc. Depreciation for the twelve months ending September 30, 2024 was $44K.
  • NovaBay Pharmaceuticals, Inc. annual Depreciation for 2023 was $51K, a 57.5% decline from 2022.
  • NovaBay Pharmaceuticals, Inc. annual Depreciation for 2022 was $120K, a 103% increase from 2021.
  • NovaBay Pharmaceuticals, Inc. annual Depreciation for 2021 was $59K.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $44K $9K -$4K -30.8% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $48K $11K -$2K -15.4% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $50K $12K -$1K -7.69% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $51K $12K Oct 1, 2023 Dec 31, 2023 10-K 2024-03-26
Q3 2023 $13K Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 $13K Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 $13K -$17K -56.7% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q1 2022 $30K Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-12
Q2 2016 $27K -$14K -34.1% Apr 1, 2016 Jun 30, 2016 10-Q 2016-08-11
Q1 2016 $40K -$1K -2.44% Jan 1, 2016 Mar 31, 2016 10-Q 2016-05-12
Q2 2015 $41K Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-11
Q1 2015 $41K Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.